BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31735642)

  • 1. Direct Visualization of Native CRISPR Target Search in Live Bacteria Reveals Cascade DNA Surveillance Mechanism.
    Vink JNA; Martens KJA; Vlot M; McKenzie RE; Almendros C; Estrada Bonilla B; Brocken DJW; Hohlbein J; Brouns SJJ
    Mol Cell; 2020 Jan; 77(1):39-50.e10. PubMed ID: 31735642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput Characterization of Cascade type I-E CRISPR Guide Efficacy Reveals Unexpected PAM Diversity and Target Sequence Preferences.
    Fu BX; Wainberg M; Kundaje A; Fire AZ
    Genetics; 2017 Aug; 206(4):1727-1738. PubMed ID: 28634160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live-cell single-particle tracking photoactivated localization microscopy of Cascade-mediated DNA surveillance.
    Turkowyd B; Müller-Esparza H; Climenti V; Steube N; Endesfelder U; Randau L
    Methods Enzymol; 2019; 616():133-171. PubMed ID: 30691641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unity among the diverse RNA-guided CRISPR-Cas interference mechanisms.
    Ganguly C; Rostami S; Long K; Aribam SD; Rajan R
    J Biol Chem; 2024 Jun; 300(6):107295. PubMed ID: 38641067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
    Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
    Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive DNA Reeling by the Cascade-Cas3 Complex in Nucleotide Unwinding Steps.
    Loeff L; Brouns SJJ; Joo C
    Mol Cell; 2018 May; 70(3):385-394.e3. PubMed ID: 29706536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems.
    Meeske AJ; Marraffini LA
    Mol Cell; 2018 Sep; 71(5):791-801.e3. PubMed ID: 30122537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
    Chaudhary K; Chattopadhyay A; Pratap D
    J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Subcellular Localization of a Type I CRISPR Complex and the Cas3 Nuclease in Bacteria.
    Govindarajan S; Borges A; Karambelkar S; Bondy-Denomy J
    J Bacteriol; 2022 May; 204(5):e0010522. PubMed ID: 35389256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRISPR RNA-guided surveillance complex in Escherichia coli accommodates extended RNA spacers.
    Luo ML; Jackson RN; Denny SR; Tokmina-Lukaszewska M; Maksimchuk KR; Lin W; Bothner B; Wiedenheft B; Beisel CL
    Nucleic Acids Res; 2016 Sep; 44(15):7385-94. PubMed ID: 27174938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure Reveals a Mechanism of CRISPR-RNA-Guided Nuclease Recruitment and Anti-CRISPR Viral Mimicry.
    Rollins MF; Chowdhury S; Carter J; Golden SM; Miettinen HM; Santiago-Frangos A; Faith D; Lawrence CM; Lander GC; Wiedenheft B
    Mol Cell; 2019 Apr; 74(1):132-142.e5. PubMed ID: 30872121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR as a strong gene editing tool.
    Shen S; Loh TJ; Shen H; Zheng X; Shen H
    BMB Rep; 2017 Jan; 50(1):20-24. PubMed ID: 27616359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
    Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and Repurposing of Type I and Type II CRISPR-Cas Systems in Bacteria.
    Hidalgo-Cantabrana C; Goh YJ; Barrangou R
    J Mol Biol; 2019 Jan; 431(1):21-33. PubMed ID: 30261168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition.
    Westra ER; Semenova E; Datsenko KA; Jackson RN; Wiedenheft B; Severinov K; Brouns SJ
    PLoS Genet; 2013; 9(9):e1003742. PubMed ID: 24039596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 Structures and Mechanisms.
    Jiang F; Doudna JA
    Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.